Kikuchi disease: A case report about Sintilimab-induced Kikuchi histiocytic necrotizing lymphadenitis and literature review

Immune checkpoint inhibitors have become one of the effective means of solid tumor treatment, among which anti-programmed death-1 (PD-1) antibodies are more maturely applied and can effectively inhibit tumor immune escape, thus enhancing the anti-tumor effect, but it can also lead to a series of imm...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Chunxiao Ren, Yuqun Wang, Xin Yang, Yinglan Tuo, Yaqiong Li, Jichang Gong
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Subjects:	Sintilimab Histiocytic necrotizing lymphadenitis Kikuchi disease Immune-related adverse events Case report
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024066398